A randomized study to evaluate tolerance, pharmacokinetics, and short term efficacy of seven doses of the short –acting formulation of ICI 182,780 in women prior to surgery for primary breast cancer.
Study identifier:9238HQ/0002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomized study to evaluate tolerance, pharmacokinetics, and short term efficacy of seven doses of the short –acting formulation of ICI 182,780 in women prior to surgery for primary breast cancer.
Medical condition
Breast Cancer
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
